摘要
三七是我国传统名贵大宗药材、具有活血散瘀,消肿定痛的功效,是预防和治疗心脑血管系统疾病的主要药物。三七产业近几年产业发展迅速,不但成为研究热点,而且在基地建设、产品开发、规模化生产等方面均取得了长促进步。本文结合云南省三七产业发展现状,分析了我国三七产业发展取得的主要成效,存在的主要问题、提出了今后发展的主要对策措施,为三七产业发展提供决策参考。
Sanqi(Panax notoginseng)is a traditional and valuable medicinal material in China.It has the effect of activating blood circulation and dispersing blood stasis,reducing swelling and fixing pain.It is the main medicine for preventing and treating cardiovascular and cerebrovascular diseases.The industry of P.notoginseng has developed rapidly in recent years,and has not only become a research hotspot.And in the base construction,product development,scale production and other aspects have made long-term progress.Based on the present development of P.notoginseng industry in Yunnan province,the main achievements and problems in the development of P.notoginseng industry of China have been analyzed.We also put forward the main countermeasures and suggestions for the future development of P.notoginseng,which may provide a reference for the decision making in the future development of P.notoginseng industry.
作者
崔秀明
黄璐琦
CUI Xiu-ming;HUANG Lu-qi(Faculty of Life Science and Technology,Kunming University of Science and Technology,Kunming 650500,China;Yunnan Key Laboratory of Panax notoginseng,Kunming 650500,China;Laboratory of sustainable utilization of Panax notoginseng Resources,State Administration of Traditional Chinese Medicine,Kunming 650500,China;National Technology System for Chinese Materia Medica Industry,Beijing 100700,China;National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处
《中国现代中药》
CAS
2018年第3期247-252,共6页
Modern Chinese Medicine
基金
云南省重大科技专项(2017ZF001)
关键词
三七
产业发展
对策建议
Panax notoginseng
industry
development
countermeasures
suggestions